How do you go about enrolling stroke patients when you have to give the drug 3 hours after they have had a stroke?
Does the patient have to pass some test that shows he/she is with it enough to make a that choice or do you have to find family members who will make that choice?
PAION announces last patient randomized in Phase III ischemic strokestudy (DIAS-2) with Desmoteplase
If it didn't have the clinical hold for 2 days the stock would now be double what it is trading for.
As people get comfortable that the trial is fully enrolled and the data should be out in 4 to 5 months for a stroke drug that could increase the window of therapy from 3 to 9 hours or more interest should get generated
News 
Market Data 
Discover 
AI
